PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
07-Jan-2020 Mobidiag Secures Additional Funding from Business Finland for Rapid Sepsis Diagnostic Test ESPOO
07-Jan-2020 Transgene and NEC Start Two Clinical Trials with TG4050, an individualized AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers Transgene
07-Jan-2020 Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME Oxurion NV
07-Jan-2020 Yseop and Litera partner to fast-track regulation submission processes for Life Sciences companies Yseop
07-Jan-2020 Sebia enters into agreement with Sanofi to develop multiple myeloma diagnostic test Sebia
03-Jan-2020 Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK Conference  SMi Group
24-Dec-2019 PharmaLink Announces Facility Expansion to Accommodate Growth PharmaLink
24-Dec-2019 Pharmaceutical Contract Manufacturing Market Fior Market Research LLP
24-Dec-2019 Venous Stents Market Fior Market Research LLP
23-Dec-2019 TEQ: Plastique brings cleanroom packaging manufacturing closer to home Plastique
23-Dec-2019 Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants Abeona Therapeutics
23-Dec-2019 Nanoform files for GMP certification Nanoform
23-Dec-2019 Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA Abeona Therapeutics Inc
23-Dec-2019 AstraZeneca’s triple-combination therapy approved in China for patients with COPD AstraZeneca
23-Dec-2019 ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV ViiV Healthcare
23-Dec-2019 Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy Roche
23-Dec-2019 Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens AstraZeneca
23-Dec-2019 U.S. FDA APPROVES EISAI’S DAYVIGO™ (LEMBOREXANT) FOR TREATMENT OF INSOMNIA IN ADULT PATIENTS Eisai Co., Ltd
23-Dec-2019 Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Following the Opening of its IND Akari Therapeutics, Plc
23-Dec-2019 Negative Pressure Wound Therapy (NPWT) Market Growth Analysis by Sale, Demand, Manufacturers P&S Intelligence